MedTrace Logo

Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease

NCT03077516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2019-12-04

No results posted yet for this study

Summary

The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies

Conditions

  • Cervical Disc Disease
  • Cervical Disc Degeneration

Interventions

DEVICE

Mobi-C

Device for cervical intervertebral disc replacement at one or two contiguous levels

Sponsors & Collaborators

  • LDR Spine USA

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2019-10-31
Completion
2019-10-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03077516 on ClinicalTrials.gov